Envista Holdings (NVST) Liabilities and Shareholders Equity (2018 - 2026)
Envista Holdings' (NVST) quarterly Liabilities and Shareholders Equity came in at $5.6 billion in Q2 2026, up 2.04% year-on-year from $5.5 billion in Q2 2025, and down 1.78% quarter-over-quarter from $5.7 billion in Q4 2025.
Envista Holdings (NVST) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends
Envista Holdings' Liabilities and Shareholders Equity history runs 9 years deep, the most recent figure standing at $5.6 billion for Q2 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 2.04% year-over-year to $5.6 billion in Q2 2026; TTM through Apr 2026 was $22.6 billion, a 3.67% increase from a year earlier, with the FY2025 full-year figure at $5.7 billion, up 6.14% from the prior year.
- Liabilities and Shareholders Equity declined to $5.6 billion in Q2 2026 per NVST's latest filing, from $5.7 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $6.7 billion in Q3 2023 and bottomed at $5.4 billion in Q4 2024.
- The 5-year median for Liabilities and Shareholders Equity is $6.4 billion (2022), against an average of $6.1 billion.
- Across the five-year window, Liabilities and Shareholders Equity dropped 18.99% in 2024 and gained 6.14% in 2025, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $6.6 billion in 2022, then advanced by 0.27% to $6.6 billion in 2023, then slipped by 18.99% to $5.4 billion in 2024, then gained by 6.14% to $5.7 billion in 2025, then decreased by 1.78% to $5.6 billion in 2026.
- Per Business Quant, the three latest NVST Liabilities and Shareholders Equity figures stand at $5.6 billion (Q2 2026), $5.7 billion (Q4 2025), and $5.6 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 31.62 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 50.83 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 39.01 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 8.78 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 14.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 6.31 Bn |
| 10 | Envista Holdings | 4.29 Bn | 3.20 Bn | 390.10 Mn | 5.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 5.58 Bn |
| Dec 31, 2025 | 5.68 Bn |
| Sep 26, 2025 | 5.64 Bn |
| Jun 27, 2025 | 5.66 Bn |
| Mar 28, 2025 | 5.47 Bn |
| Dec 31, 2024 | 5.35 Bn |
| Sep 27, 2024 | 5.51 Bn |
| Jun 28, 2024 | 5.44 Bn |
| Mar 29, 2024 | 6.56 Bn |
| Dec 31, 2023 | 6.61 Bn |
| Sep 29, 2023 | 6.68 Bn |
| Jun 30, 2023 | 6.61 Bn |
| Mar 31, 2023 | 6.58 Bn |
| Dec 31, 2022 | 6.59 Bn |
| Sep 30, 2022 | 6.41 Bn |
| Jul 1, 2022 | 6.46 Bn |
| Apr 1, 2022 | 6.57 Bn |
| Dec 31, 2021 | 6.57 Bn |
| Oct 1, 2021 | 6.56 Bn |
| Jul 2, 2021 | 6.48 Bn |